Article
Integrated single-cell analysis reveals heterogeneity and therapeutic insights in osteosarcoma
18 Nov 2024
Abstract excerpt
Osteosarcoma (OSA) is a primary bone malignancy characterized by its aggressive nature and high propensity for metastasis. Despite advancements in multimodal therapies, the clinical outcomes for OSA patients remain suboptimal, necessitating deeper molecular insights for improved therapeutic strategies. Here, we employed single-cell RNA sequencing (scRNA-seq) to elucidate the cellular heterogeneity and...
Topics
Join the communities discussing this publication.
